Alpha Cognition Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACOG and other ETFs, options, and stocks.About ACOG
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. It has additional pre-clinical development programs: ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease, ALPHA-1062 sublingual formulation, ALPHA-1062 intranasal (“ALPHA-1062IN”) formulation for the treatment of cognitive impairment with mild traumatic brain injury (mTBI, otherwise known as concussion) and ALPHA-0602, ALPHA-0702 & ALPHA-0802.
CEOMichael E. McFadden
CEOMichael E. McFadden
Employees—
Employees—
HeadquartersGrapevine, Texas
HeadquartersGrapevine, Texas
Founded2000
Founded2000
Employees—
Employees—
ACOG Key Statistics
Market cap139.63M
Market cap139.63M
Price-Earnings ratio-4.31
Price-Earnings ratio-4.31
Dividend yield—
Dividend yield—
Average volume87.70K
Average volume87.70K
High today$6.92
High today$6.92
Low today$6.55
Low today$6.55
Open price$6.85
Open price$6.85
Volume82.30K
Volume82.30K
52 Week high$11.54
52 Week high$11.54
52 Week low$3.75
52 Week low$3.75
People also own
Based on the portfolios of people who own ACOG. This list is generated using Robinhood data, and it’s not a recommendation.